Cargando…
Reply to Q. Chu et al
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Clinical Oncology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081511/ https://www.ncbi.nlm.nih.gov/pubmed/33529075 http://dx.doi.org/10.1200/GO.20.00531 |
| _version_ | 1783685656238620672 |
|---|---|
| author | Semprini, Jason T. Olopade, Olufunmilayo I. |
| author_facet | Semprini, Jason T. Olopade, Olufunmilayo I. |
| author_sort | Semprini, Jason T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8081511 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Society of Clinical Oncology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80815112021-05-04 Reply to Q. Chu et al Semprini, Jason T. Olopade, Olufunmilayo I. JCO Glob Oncol Correspondence American Society of Clinical Oncology 2021-02-02 /pmc/articles/PMC8081511/ /pubmed/33529075 http://dx.doi.org/10.1200/GO.20.00531 Text en © 2021 by American Society of Clinical Oncology https://creativecommons.org/licenses/by/4.0/Licensed under the Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Correspondence Semprini, Jason T. Olopade, Olufunmilayo I. Reply to Q. Chu et al |
| title | Reply to Q. Chu et al |
| title_full | Reply to Q. Chu et al |
| title_fullStr | Reply to Q. Chu et al |
| title_full_unstemmed | Reply to Q. Chu et al |
| title_short | Reply to Q. Chu et al |
| title_sort | reply to q. chu et al |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081511/ https://www.ncbi.nlm.nih.gov/pubmed/33529075 http://dx.doi.org/10.1200/GO.20.00531 |
| work_keys_str_mv | AT semprinijasont replytoqchuetal AT olopadeolufunmilayoi replytoqchuetal |